The pit (of sleeplessness) and the pendulum (of regulation)

Sleep Medicine

Volumn 11, Issue 1, 2010, Pages 7-8

  Bliwise, Donald L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; EVT 201; TRIAZOLAM; UNCLASSIFIED DRUG;

AGING; ANXIETY DISORDER; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; COGNITION; DAYTIME SOMNOLENCE; DOSE RESPONSE; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; EDITORIAL; ELDERLY CARE; FUNCTIONAL ASSESSMENT; HUMAN; INSOMNIA; MOOD DISORDER; NIGHT SLEEP; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SLEEP TIME; TASK PERFORMANCE;

AGE FACTORS; AGED; BENZODIAZEPINES; CROSS-SECTIONAL STUDIES; DEMENTIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG APPROVAL; HUMANS; HYPNOTICS AND SEDATIVES; NEUROPSYCHOLOGICAL TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, GABA-A; SLEEP INITIATION AND MAINTENANCE DISORDERS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WAKEFULNESS;

EID: 73149124272     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.08.002     Document Type: Editorial

References (13)

1. Strine T.W., and Chapman D.P. Associations of frequent sleep insufficiency with health-related quality of life and health behaviors. Sleep Med 6 (2005) 23-27
2. Naidoo N., Giang W., Galante R.J., and Pack A.I. Sleep deprivation induces the unfolded protein response in mouse cerebral cortex. J Neurochem 92 (2005) 1150-1157
3. Naidoo N., Ferber M., Master M., Zhu Y., and Pack A.I. Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J Neurosci 28 (2008) 6539-6548
4. McCurry S.M., Gibbons L.E., Logsdon R.G., Vitiello M.V., and Teri L. Nighttime insomnia treatment and education for Alzheimer's Disease: a randomized, controlled trial. J Am Geriatr Soc 53 (2005) 793-802
5. Walsh J.K., Salkeld L., Knowles L.J., Tasker T., and Hunneyball I. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance and daytime sleepiness. Sleep Med 11 1 (2010) 23-30
6. Yaffe K., Blackwell T., Barnes D.E., Ancoli-Israel S., and Stone K.L. Study of Osteoporotic Fractures Group. Preclinical cognitive decline and subsequent sleep disturbance in older women. Neurology 69 (2007) 237-242
7. Bliwise D.L., Carskadon M.A., Seidel W.F., Nekich J.C., and Dement W.C. MSLT-defined sleepiness and neuropsychological test performance do not correlate in the elderly. Neurobiol Aging 12 (1991) 463-468
8. Carskadon M.A., Seidel W.F., Greenblatt D.J., and Dement W.C. Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 5 (1982) 361-371
9. Bliwise D., Seidel W., Karacan I., Mitler M., Roth T., Zorick F., et al. Daytime sleepiness as a criterion in hypnotic medication trials: Comparison of triazolam and flurazepam. Sleep 6 (1983) 156-163
10. Bliwise D.L., Seidel W.F., Cohen S.A., Bliwise N.G., and Dement W.C. Profile of Mood State (POMS) changes during and after five weeks of nightly triazolam administration. J Clin Psychiatr 49 (1988) 349-355
11. Kripke D.F. Possibility that certain hypnotics might cause cancer in skin. J Sleep Res 17 (2008) 245-250
12. Bliwise D.L., and Ansari F.P. Insomnia associated with valerian and melatonin usage in the 2002 National Health Interview Survey. Sleep 30 (2007) 881-884
13. Hilts P.J. Protecting America's health (2003), Knopf, New York